Dual targeting of the mitochondrial Lon peptidase 1 and the chymotrypsin-like proteasome activity as a potential therapeutic strategy in malignant astrocytoma models is a research paper published in Pharmacological Research (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: UL1 TR001414
American Cancer Society
Grant: ACS/IRG \u2013 98-279- 07
National Institutes of Health
Grant: NS111303
University of Arizona Cancer Center
Grant: P30CA062203
NINDS
Grant: NS109423
National Institutes of Health
Grant: 3P30CA062203-27S1
Clinical Trial Advancement and Development for Sarcomas
National Institutes of Health
Grant: 3UL1TR001414-06S1
THE SEARCH FOR COVID-19 PREVENTION AND CURE: ADDRESSING THE CRITICAL ROLE OF INNATE/ADAPTIVE IMMUNITY BY INTEGRATING NOVEL INFORMATICS, TRANSLATIONAL TECHNOLOGIES, AND ONGOING CLINICAL TRIAL RESEARCH
National Institutes of Health
Grant: 1R21NS111303-01
Novel recognition and targeting of temozolomide resistant cells in glioblastoma
National Institutes of Health
Grant: 2T32CA009054-41
A Training Program for Interdisciplinary Cancer Research
National Institutes of Health
Grant: 3R01NS109423-05S1
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
FWCI
2.38
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals